Cargando…

Surfactant alteration and replacement in acute respiratory distress syndrome

The acute respiratory distress syndrome (ARDS) is a frequent, life-threatening disease in which a marked increase in alveolar surface tension has been repeatedly observed. It is caused by factors including a lack of surface-active compounds, changes in the phospholipid, fatty acid, neutral lipid, an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Günther, Andreas, Ruppert, Clemens, Schmidt, Reinhold, Markart, Philipp, Grimminger, Friedrich, Walmrath, Dieter, Seeger, Werner
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2001
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC64803/ https://www.ncbi.nlm.nih.gov/pubmed/11737935 http://dx.doi.org/10.1186/rr86

Ejemplares similares

Time-dependent changes in pulmonary surfactant function and composition in acute respiratory distress syndrome due to pneumonia or aspiration
por: Schmidt, Reinhold, et al.
Publicado: (2007)

Alveolar surfactant and adult respiratory distress syndrome: Pathogenetic role and therapeutic prospects
por: Seeger, W., et al.
Publicado: (1993)

Dry powder nebulization of a recombinant surfactant protein C-based surfactant for treatment of acute respiratory distress syndrome
por: Ruppert, C, et al.
Publicado: (2007)

Impairment of hypoxic pulmonary vasoconstriction in acute respiratory distress syndrome
por: Gierhardt, Mareike, et al.
Publicado: (2021)

Contribution of HMSE-1 to surfactant conversion under acute inflammatory conditions
por: Ruppert, C, et al.
Publicado: (2007)

Transgenic mice expressing a surfactant protein B–urokinase fusion protein in the distal respiratory epithelium are protected against acute lung injury and postinflammatory fibrosis
por: Markart, P, et al.
Publicado: (2007)

Irrational prescription of surfactant replacement therapy in neonatal respiratory distress
por: Jahanmehr, Nader, et al.
Publicado: (2022)

Multiorganinfektionen — komplexe klinisch-infektiologische Krankheiten
por: Bergmann, Frank, et al.
Publicado: (2005)

History of Pulmonary Surfactant Replacement Therapy for Neonatal Respiratory Distress Syndrome in Korea
por: Bae, Chong-Woo, et al.
Publicado: (2019)

Surfactant replacement therapy in acute respiratory distress syndrome from viral pneumonia
por: Putz, G., et al.
Publicado: (1996)

Extracorporeal Carbon Dioxide Removal Using a Renal Replacement Therapy Platform to Enhance Lung-Protective Ventilation in Hypercapnic Patients With Coronavirus Disease 2019-Associated Acute Respiratory Distress Syndrome
por: Husain-Syed, Faeq, et al.
Publicado: (2020)

Surfactant replacement therapy for non-respiratory distress syndrome neonatal respiratory disease —research or clinical application?
por: Greenough, Anne
Publicado: (1995)

The Role of Surfactant in Respiratory Distress Syndrome
por: Ma, Christopher Cheng-Hwa, et al.
Publicado: (2012)

Surfactant replacement therapy for respiratory distress syndrome in preterm infants: United Kingdom national consensus
por: Banerjee, Sujoy, et al.
Publicado: (2019)

Altered molecular specificity of surfactant phosphatidycholine synthesis in patients with acute respiratory distress syndrome
por: Dushianthan, Ahilanandan, et al.
Publicado: (2014)

Pulmonary Surfactant Replacement Therapy for Respiratory Distress Syndrome in Neonates: a Nationwide Epidemiological Study in Korea
por: Shin, Jeong Eun, et al.
Publicado: (2020)

Surfactant replacement and open lung concept – Comparison of two treatment strategies in an experimental model of neonatal ARDS
por: Hilgendorff, Anne, et al.
Publicado: (2008)

Smoking: Is it a risk factor for pulmonary vascular diseases?
por: Weissmann, Norbert, et al.
Publicado: (2012)

Exogenous surfactant therapy for acute respiratory distress in infancy
por: Moreno, M., et al.
Publicado: (1996)

Aerosolized Surfactant for Preterm Infants with Respiratory Distress Syndrome
por: Brasher, Mandy, et al.
Publicado: (2021)

Health Economic Studies of Surfactant Replacement Therapy in Neonates with Respiratory Distress Syndrome: A Systematic Literature Review
por: Magni, Tiziana, et al.
Publicado: (2023)

Lungengefäßerkrankungen
por: Ghofrani, A., et al.
Publicado: (2008)

Cell-Specific Nitric Oxide Synthase-Isoenzyme Expression and Regulation in Response to Endotoxin in Intact Rat Lungs
por: Ermert, Monika, et al.
Publicado: (2002)

Plasminogen Activator Inhibitor-1 Is an Inhibitor of Factor VII-activating Protease in Patients with Acute Respiratory Distress Syndrome
por: Wygrecka, Malgorzata, et al.
Publicado: (2007)

Prehospital administration of surfactant to a premature neonate in respiratory distress
por: Mize, Charles Haviland, et al.
Publicado: (2019)

Trial of aerosolised surfactant for preterm infants with respiratory distress syndrome
por: Jardine, Luke, et al.
Publicado: (2022)

Target product profile: aerosolized surfactant for neonatal respiratory distress
por: Rao, Suman, et al.
Publicado: (2023)

FiO(2) Before Surfactant, but Not Time to Surfactant, Affects Outcomes in Infants With Respiratory Distress Syndrome
por: Kruczek, Piotr, et al.
Publicado: (2021)

Altered Lipid Composition of Surfactant and Lung Tissue in Murine Experimental Malaria-Associated Acute Respiratory Distress Syndrome
por: Scaccabarozzi, Diletta, et al.
Publicado: (2015)

Surfactant Protein D Is Altered in Experimental Malaria-Associated Acute Lung Injury/Acute Respiratory Distress Syndrome
por: Punsawad, Chuchard, et al.
Publicado: (2019)

Early Surfactant Therapy for Respiratory Distress Syndrome in Very Preterm Infants
por: Cucerea, Manuela, et al.
Publicado: (2023)

Pulmonary surfactant combined with budesonide in the treatment of neonatal respiratory distress syndrome
por: Guo, Hongxing, et al.
Publicado: (2023)

FoxO3 an important player in fibrogenesis and therapeutic target for idiopathic pulmonary fibrosis
por: Al‐Tamari, Hamza M, et al.
Publicado: (2017)

Multiorganinfektionen — komplexe klinisch infektiologische Krankheiten
por: Walmrath, Hans-Dieter, et al.
Publicado: (2007)

Changes in dead space/tidal volume ratio and pulmonary mechanics after surfactant replacement therapy in respiratory distress syndrome of the newborn infants.
por: Chung, E. H., et al.
Publicado: (2001)

Efficacy and safety of surfactant replacement therapy for preterm neonates with respiratory distress syndrome in low- and middle-income countries: a systematic review
por: Sankar, M J, et al.
Publicado: (2016)

Lung Mechanics in COVID-19 Resemble Respiratory Distress Syndrome, Not Acute Respiratory Distress Syndrome: Could Surfactant Be a Treatment?
por: Koumbourlis, Anastassios C., et al.
Publicado: (2020)

Mechanical ventilation-induced alterations of intracellular surfactant pool and blood–gas barrier in healthy and pre-injured lungs
por: Krischer, Jeanne-Marie, et al.
Publicado: (2020)

Two Mutations in Surfactant Protein C Gene Associated with Neonatal Respiratory Distress
por: Tarocco, Anna, et al.
Publicado: (2015)

Turkish Neonatal Society guideline on the management of respiratory distress syndrome and surfactant treatment
por: Özkan, Hasan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1lmiatj5d6b2s30pnb3vr59ea9